EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 3 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $835,000 | -83.2% | 1,847,500 | 0.0% | 0.04% | -86.3% |
| Q1 2016 | $4,970,000 | -12.9% | 1,847,500 | 0.0% | 0.29% | -21.1% |
| Q4 2015 | $5,709,000 | -30.1% | 1,847,500 | 0.0% | 0.37% | -47.3% |
| Q3 2015 | $8,166,000 | -22.6% | 1,847,500 | 0.0% | 0.70% | -2.5% |
| Q2 2015 | $10,549,000 | -36.2% | 1,847,500 | 0.0% | 0.72% | -39.2% |
| Q1 2015 | $16,535,000 | – | 1,847,500 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,265,988 | $12,939,000 | 1.30% |
| Camber Capital Management LP | 1,847,500 | $10,549,000 | 0.72% |
| Cormorant Asset Management, LP | 896,600 | $5,120,000 | 0.68% |
| SOUTHPORT MANAGEMENT, L.L.C. | 50,000 | $286,000 | 0.37% |
| Broadfin Capital, LLC | 775,000 | $4,425,000 | 0.24% |
| BAILARD, INC. | 246,431 | $1,407,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,223,922 | $12,699,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 126,807 | $724,000 | 0.05% |
| ARDSLEY ADVISORY PARTNERS LP | 25,000 | $143,000 | 0.02% |
| Spark Investment Management LLC | 17,900 | $102,000 | 0.01% |